Clinical Trial Update: Study of Sulphoraphane in Chronic Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating sulforaphane in chronic kidney disease (stages 3 and 4) has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: University of Rochester | Conditions: Chronic Kidney Disease stage3, Chronic Kidney Disease stage4 | Phase 1 | Status: COMPLETED | Results posted: 2024-08-12